ライフサイエンスコーパス: paraparesis

1 TLV-1-associated myelopathy-tropical spastic paraparesis.

2 TLV-I-associated myelopathy/tropical spastic paraparesis.

3 in debilitating leukodystrophies and spastic paraparesis.

4 ents with HTLV-II seropositivity and spastic paraparesis.

5 TLV-1-associated myelopathy/tropical spastic paraparesis.

6 TLV-1-associated myelopathy/tropical spastic paraparesis.

7 or neuron disorders characterized by spastic paraparesis.

8 sive gait ataxia with a superimposed spastic paraparesis.

9 TLV-I-associated myelopathy/tropical spastic paraparesis.

10 1 null mice in addition to prominent spastic paraparesis.

11 TLV-1-associated myelopathy/tropical spastic paraparesis.

12 TLV-I-associated myelopathy/tropical spastic paraparesis.

13 TLV-I-associated myelopathy/tropical spastic paraparesis.

14 ype I-associated myelopathy/tropical spastic paraparesis.

15 ype I-associated myelopathy/tropical spastic paraparesis.

16 ype I-associated myelopathy/tropical spastic paraparesis.

17 , with limb and gait ataxia and mild spastic paraparesis.

18 affected by Alzheimer's disease with spastic paraparesis.

19 TLV-I-associated myelopathy/tropical spastic paraparesis.

20 TLV-1-associated myelopathy/tropical spastic paraparesis.

21 HTLV-I-associated myopathy/tropical spastic paraparesis.

22 which is, in most cases, preceded by spastic paraparesis.

23 hology of HTLV-1-associated/tropical spastic paraparesis.

24 TLV-1-associated myelopathy/tropical spastic paraparesis?

25 Thirty-five patients had paraplegia or paraparesis (5.4%).

26 ed, patients frequently present with spastic paraparesis, a thin corpus callosum, and cognitive impai

27 rus-1-associated myelopathy/tropical spastic paraparesis, A6 also recognizes a self peptide from the

28 ined independent association with paraplegia-paraparesis after multivariate analysis.

29 TLV-1-associated myelopathy/tropical spastic paraparesis after the initial infection.

30 tis, cervical myelopathy from syringomyelia, paraparesis, amenorrhea-galactorrhea, and other endocrin

31 TLV-1-associated myelopathy/tropical spastic paraparesis and adult T cell leukemia.

32 a similar combination of progressive spastic paraparesis and polyneuropathy, variably associated with

33 A man in his 30s with paraparesis and urinary incontinence had a long-segment

34 motor CD (nine with hemiparesis and six with paraparesis) and 25 age- and gender-matched healthy volu

35 TLV-1-associated myelopathy/tropical spastic paraparesis, and HTLV-1-associated uveitis.

36 phalomyeloradiculitis had a moderate flaccid paraparesis, and the patient with subacute meningomyelor

37 TLV-I-associated myelopathy/tropical spastic paraparesis), by reducing the proviral load of HTLV-I; h

38 TLV-I-associated myelopathy/tropical spastic paraparesis, characterized pathologically by inflammatio

39 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T cell leukemia/lymphoma

40 TLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) and chronic Lyme neuroborreliosis.

41 LV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS).

42 LV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS).

43 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) are known to be caused by HTLV-I i

44 ype I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) based on newly developed molecular

45 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) exhibit reduced Foxp3 expression a

46 LV-I-associated) myelopathy/tropical spastic paraparesis (HAM/TSP) has been shown to be a major reser

47 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic, progressive neurolog

48 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a neurological disease that res

49 LV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a progressive inflammatory myel

50 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an immune-mediated inflammatory

51 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammatory neurologic dise

52 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammatory neurologic dise

53 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is associated with immunoreactivit

54 TLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) is poorly understood.

55 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) proliferate spontaneously in vitro

56 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) results in a decrease in FOXP3 mRN

57 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a chronic inflammatory disease of

58 LV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a disease that can be indistingui

59 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an immune-mediated disorder of th

60 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), mono- or oligoclonal expansions w

61 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), observed in up to 5% of infected

62 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

63 ted myelopathy, also called tropical spastic paraparesis (HAM/TSP).

64 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

65 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

66 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

67 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

68 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

69 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

70 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

71 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

72 rus I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

73 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

74 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

75 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

76 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

77 TLV-I-associated myelopathy/tropical spastic paraparesis [HAM/TSP]) is suggested to be an immunopatho

78 ype I-associated myelopathy/tropical spastic paraparesis has been reported and is thought to be relat

79 We studied a case of Hereditary Spastic Paraparesis (HSP) in a single inbred Palestinian family.

80 found in ex vivo samples of tropical spastic paraparesis-HTLV-1-associated myelopathy patients contai

81 ion of different alleles in tropical spastic paraparesis-HTLV-associated myelopathy and ATLL or healt

82 neurodegenerative disorder tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).

83 -cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopathy in about 5% of

84 -cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopathy, among other di

85 eukemia/lymphoma as well as tropical spastic paraparesis/HTLV-1-associated myelopathy.

86 r adult T-cell leukemia and tropical spastic paraparesis/HTLV-I-associated myelopathy.

87 d the neurological disorder tropical spastic paraparesis/HTLV-I-associated myelopathy.

88 iency is a rare cause of complicated spastic paraparesis in adults, it should be considered in select

89 d myelopathy (also known as tropical spastic paraparesis), infective dermatitis of children and uveit

90 ype I-associated myelopathy/tropical spastic paraparesis is a chronic progressive inflammatory neurol

91 TLV-1) -associated myelopathy/tropic spastic paraparesis is a demyelinating inflammatory neurologic d

92 Spastic paraparesis is thought to be an occasional manifestation

93 ed novel clinical presentations with spastic paraparesis mimicking hereditary spastic paraplegia, and

94 s adult T-cell leukemia and tropical spastic paraparesis/myelopathy.

95 parkinsonism (n = 1), and hereditary spastic paraparesis (n = 1).

96 Three cases of transient paraparesis occurred (all in patients requiring mesenter

97 l manifestations, including tropical spastic paraparesis or HTLV-1-associated myelopathy (TSP/HAM).

98 stoperative spinal cord injury manifested as paraparesis or paraplegia of 9.9% (9/91).

99 Paraparesis-paraplegia occurred in 7%, an incidence sign

100 cated form of adult-onset hereditary spastic paraparesis partially responsive to betaine therapy.

101 HTLV-1-associated myelopathy/tropic spastic paraparesis patients carried a significant number (up to

102 ype I-associated myelopathy/tropical spastic paraparesis patients using real-time quantitative polyme

103 rus I-associated myelopathy/tropical spastic paraparesis, rheumatoid arthritis, multiple sclerosis an

104 TLV-1-associated myelopathy/tropical spastic paraparesis risk.

105 Neurosensory hearing loss, ataxia, spastic paraparesis, sphincter dysfunction, somatosensory distur

106 TLV-I-associated myelopathy/tropical spastic paraparesis suggest that HTLV-I may infect other cell ty

107 TLV-1-associated myelopathy/tropical spastic paraparesis than in 29 asymptomatic carriers (80% vs 20%

108 associated myelopathy (HAM)/tropical spastic paraparesis (TSP)] and subcortical ischaemic damage.

109 TLV-1-associated myelopathy/tropical spastic paraparesis was associated with a lower expression (comp

110 TLV-1-associated myelopathy/tropical spastic paraparesis was associated with significantly increased

111 rodegenerative subtype of lower limb spastic paraparesis with additional diffuse skin and hair dyspig